Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation

IF 10.3 1区医学 Q1 CLINICAL NEUROLOGY

Acta Neuropathologica Pub Date : 2026-09-04 DOI:10.1007/s00401-026-03081-8

Julia Konings, Fleur Mingneau, Serhii Chornyi, Cathrin E. Hansen, Rianne T. M. van der Burgt, Tessa G. van Elk, Laura Bolkaerts, Bo Batens, Gábor Tóth, Ingela Lanekoff, Frédéric M. Vaz, Alessio Cardilli, Marie Sels, Susanne M. A. van der Pol, Helga E. de Vries, Martin Giera, Oliver Werz, Sofie Kessels, Sanne G. S. Verberk, Jeroen F. J. Bogie, Merel Rijnsburger, Jerome J. A. Hendriks, Gijs Kooij

引用次数: 0

查看原文本刊更多论文

更正：小胶质5- lox激活蛋白拮抗剂可减轻白三烯驱动的神经炎症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Neuropathologica 医学-病理学

CiteScore

23.70

自引率

3.90%

发文量

118

审稿时长

4-8 weeks

期刊介绍： Acta Neuropathologica publishes top-quality papers on the pathology of neurological diseases and experimental studies on molecular and cellular mechanisms using in vitro and in vivo models, ideally validated by analysis of human tissues. The journal accepts Original Papers, Review Articles, Case Reports, and Scientific Correspondence (Letters). Manuscripts must adhere to ethical standards, including review by appropriate ethics committees for human studies and compliance with principles of laboratory animal care for animal experiments. Failure to comply may result in rejection of the manuscript, and authors are responsible for ensuring accuracy and adherence to these requirements.